What does CUSIP 03237H901 represent in this 13F holders report?

CUSIP 03237H901 is the security identifier for 03237H901 - AMYLYX PHARMACEUTICALS INC - CALL used to aggregate holder disclosures.

How many institutions held 03237H901 - AMYLYX PHARMACEUTICALS INC - CALL in Q4 2023?

No institutional holders were reported for 03237H901 - AMYLYX PHARMACEUTICALS INC - CALL in Q4 2023; review adjacent reporting periods for trend context.

AMYLYX PHARMACEUTICALS INC - CALL

CUSIP: 03237H901

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / CALL
Price per share: $14.72
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 03237H901?
CUSIP 03237H901 identifies 03237H901 - AMYLYX PHARMACEUTICALS INC - CALL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 03237H901:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

AMYLYX PHARMACEUTICALS INC - CALL

Q4 2023 13F Holders as of 31 Dec 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of AMYLYX PHARMACEUTICALS INC - CALL as of Q4 2023.